JPH0262818A - Hair-tonic composition - Google Patents
Hair-tonic compositionInfo
- Publication number
- JPH0262818A JPH0262818A JP21194788A JP21194788A JPH0262818A JP H0262818 A JPH0262818 A JP H0262818A JP 21194788 A JP21194788 A JP 21194788A JP 21194788 A JP21194788 A JP 21194788A JP H0262818 A JPH0262818 A JP H0262818A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- minoxidil
- acid ester
- glycerol
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229960003632 minoxidil Drugs 0.000 claims abstract description 26
- -1 glycerol dicapric acid ester Chemical class 0.000 claims abstract description 21
- 150000002148 esters Chemical class 0.000 claims description 5
- BJRXGOFKVBOFCO-UHFFFAOYSA-N 2-hydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(C)O BJRXGOFKVBOFCO-UHFFFAOYSA-N 0.000 claims description 4
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 7
- 206010040880 Skin irritation Diseases 0.000 abstract description 5
- 231100000475 skin irritation Toxicity 0.000 abstract description 5
- 230000036556 skin irritation Effects 0.000 abstract description 5
- 239000003921 oil Substances 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 230000007547 defect Effects 0.000 abstract description 2
- 239000003755 preservative agent Substances 0.000 abstract description 2
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 239000000645 desinfectant Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 21
- 230000003779 hair growth Effects 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 3
- 230000037308 hair color Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229930007845 β-thujaplicin Natural products 0.000 description 3
- 208000019300 CLIPPERS Diseases 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 229940008396 carrot extract Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 2
- 229940043276 diisopropanolamine Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- LEGILXNWHFHFQF-UHFFFAOYSA-N octanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCC(O)=O.CCCCCCCC(O)=O LEGILXNWHFHFQF-UHFFFAOYSA-N 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-WFJWTYAKSA-N (2s,4as,6as,6br,10s,12as)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid Chemical compound C12C(=O)C=C3C4C[C@@](C)(C(O)=O)CC[C@]4(C)CC[C@@]3(C)[C@]1(C)CCC1[C@]2(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-WFJWTYAKSA-N 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VTHUYJIXSMGYOQ-KOORYGTMSA-N 17-hydroxyprogesterone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 VTHUYJIXSMGYOQ-KOORYGTMSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- UWLPCYBIJSLGQO-UHFFFAOYSA-N dodecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCC(O)=O UWLPCYBIJSLGQO-UHFFFAOYSA-N 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229960003517 isothipendyl Drugs 0.000 description 1
- OQJBSDFFQWMKBQ-UHFFFAOYSA-N isothipendyl Chemical compound C1=CN=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 OQJBSDFFQWMKBQ-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 239000003915 liquefied petroleum gas Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000810 peripheral vasodilating agent Substances 0.000 description 1
- 229960002116 peripheral vasodilator Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明はミノキシジルの経皮吸収を高めた優れた養毛組
成物に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to an excellent hair nourishing composition that enhances transdermal absorption of minoxidil.
[従来の技術]
ミノキシジルに養毛効果があることが発見されて以来(
米国特許公報第4139619号)、ミノキシジルを用
いた養毛剤が開発されてきているが、ミノキシジルの経
皮吸収率が低いため、養毛効果は十分なものではなかっ
た。[Prior art] Ever since it was discovered that minoxidil has a hair-growth effect (
Although hair growth agents using minoxidil have been developed (US Pat. No. 4,139,619), the hair growth effect was not sufficient due to the low transdermal absorption rate of minoxidil.
そこで、ミノキシジルの経皮吸収を促進する様々な物質
を添加した養毛剤が検討されている。Therefore, hair tonics containing various substances that promote the transdermal absorption of minoxidil are being considered.
[発明が解決しようとする課題]
これらの中には、ミノキシジルの経皮吸収率を比較的高
めたものもあるが、ミノキシジル経皮吸収促進助剤とし
て用いる化合物が常温で固体のために、皮膚塗布時に頭
髪がごわごわしたり、あるいは皮膚刺激性のため皮膚を
損傷するという欠点があった。[Problems to be Solved by the Invention] Some of these drugs have a relatively high transdermal absorption rate of minoxidil, but because the compound used as a minoxidil transdermal absorption promoting agent is solid at room temperature, It has disadvantages in that it makes the hair stiff when applied, and it irritates the skin, causing damage to the skin.
このような欠点を有するということは養毛剤として使用
に耐えず、実用的でないことを意味する。Having such defects means that it cannot be used as a hair nourishing agent and is not practical.
[課題を解決するための手段]
本発明者らは、かかる課題を解決するために鋭意研究を
進めた結果、ある特定のエステルの存在下、ミノキシジ
ルを頭髪に塗布すれば、前記欠点がなく、かつミノキシ
ジルの経皮吸収性が顕著に改善されることを見出し、本
発明を完成した。[Means for Solving the Problem] As a result of intensive research to solve the problem, the present inventors found that if minoxidil is applied to the hair in the presence of a specific ester, the above-mentioned drawbacks will not occur. They also found that the percutaneous absorption of minoxidil was significantly improved, and completed the present invention.
すなわち、本発明は、グリセリンジカプリン酸エステル
、グリセリンジカプリル酸エステル、グツセリンモノイ
ソステアリン酸エステル及びプロピレングリコールモノ
イソステアリン酸エステルから選ばれるエステルの1種
又は2種以上とミノキシジルを含有することを特徴とす
る養毛組成物である。That is, the present invention is characterized by containing one or more esters selected from glycerin dicapric acid ester, glycerin dicaprylic acid ester, gutsselin monoisostearate, and propylene glycol monoisostearate and minoxidil. It is a hair nourishing composition.
本発明において、ミノキシジルの配合量は、製剤全量の
0.05〜5.0重量%であり、0.2〜2.0重量%
が好ましい。In the present invention, the blending amount of minoxidil is 0.05 to 5.0% by weight of the total amount of the preparation, and 0.2 to 2.0% by weight.
is preferred.
また、これらエステルの配合量は、ミノキシジルの経皮
吸収を促進するに十分な量であればよく、組成物全量の
05〜30重量%、好ましくは、1〜20重量%である
。The amount of these esters may be sufficient as long as it promotes transdermal absorption of minoxidil, and is 05 to 30% by weight, preferably 1 to 20% by weight, based on the total amount of the composition.
本発明の組成物においては、この他通常養毛剤に用いら
れる物質を配合することができる。In the composition of the present invention, other substances commonly used in hair nourishing agents can be blended.
例えば、プロピレングリコール、グリセリン、ジグリセ
リン等の保湿剤、エチルアルコール、イソプロピルアル
コール、精製水等の溶媒、保存剤(パラベン類等)、油
分(ビタミンA、ビタミンB1 ビタミンC1ビタミン
D、ビタミンE1m動式ラフイン、セチルアルコール、
スクワラン、オノーブ油等)、殺菌剤(イオウ、グルコ
ン酸クロルヘキシジン、イソプロピルメチルフェノール
、第4級アンモニウム塩、ヒノキチオール等)、界面活
性剤(ポリオキシエチレン脂肪酸エステル、ソルビタン
脂肪酸エステル、グリセリンモノ膚肪酸エステル、ポリ
オキシエチレン硬化ヒマシ油誘導体等)、ゲル化剤(メ
チルセルロース、ヒドロキシプロピルセルロース、カル
ボキシビニルポリマー等)、pH調整剤(ジイソプロパ
ツールアミン等)、酸化防止剤(ジブチルヒドロキシト
ルエン等)、清涼剤(J2−メントール等)、抗炎症剤
(グリチルレチン酸、グアイアズレン等)、末梢血管拡
張剤(酢酸トコフェロール、ニコチン酸ベンジル、ニン
ジンエキス、センブリ抽出エキス、トウガラシエキス等
)、副腎皮質ホルモン(酢酸ハイドロコーチシン、吉草
酸ベタメタシン、酪酸プロピオン酸ハイドロコーチシン
等)、抗ヒスタミン剤(塩酸ジフェンヒドラミン、塩酸
イソチペンジル等)、局所麻酔剤(塩酸ジブカイン、塩
酸ノドカイン等)、角質溶解剤(尿素、サリチル酸等)
、卵胞ホルモン(17β−エストラジオール、エストロ
ン等)、黄体ホルモン(プロゲステロン、17α−ヒド
ロキシプロゲステロンアセテート等)、抗アンドロゲン
剤(シブロチロンアセテート、4−アンドロステン−3
−オン−17β−カルボキシリックアシッド等)、゛香
料、金属イオン封鎖剤、紫外線吸収剤、色素などを本発
明の効果を損なわない範囲で配合することができる。For example, moisturizing agents such as propylene glycol, glycerin, and diglycerin, solvents such as ethyl alcohol, isopropyl alcohol, and purified water, preservatives (parabens, etc.), and oils (vitamin A, vitamin B1, vitamin C1, vitamin D, and vitamin E1). Rough-in, cetyl alcohol,
squalane, onobe oil, etc.), bactericidal agents (sulfur, chlorhexidine gluconate, isopropylmethylphenol, quaternary ammonium salts, hinokitiol, etc.), surfactants (polyoxyethylene fatty acid ester, sorbitan fatty acid ester, glycerin monofatty acid ester) , polyoxyethylene hydrogenated castor oil derivatives, etc.), gelling agents (methylcellulose, hydroxypropylcellulose, carboxyvinyl polymer, etc.), pH adjusters (diisopropanolamine, etc.), antioxidants (dibutylhydroxytoluene, etc.), cooling agents agents (J2-menthol, etc.), anti-inflammatory agents (glycyrrhetinic acid, guaiazulene, etc.), peripheral vasodilators (tocopherol acetate, benzyl nicotinate, carrot extract, Jasmine japonica extract, capsicum extract, etc.), adrenocortical hormones (hydrocoach acetate, etc.) antihistamines (diphenhydramine hydrochloride, isothipendyl hydrochloride, etc.), local anesthetics (dibucaine hydrochloride, nodocaine hydrochloride, etc.), keratolytic agents (urea, salicylic acid, etc.)
, follicular hormones (17β-estradiol, estrone, etc.), progesterone (progesterone, 17α-hydroxyprogesterone acetate, etc.), anti-androgens (cibrothyrone acetate, 4-androstene-3, etc.)
-one-17β-carboxylic acid, etc.), fragrances, sequestering agents, ultraviolet absorbers, pigments, etc., may be incorporated within the range that does not impair the effects of the present invention.
本発明の養毛組成物は、通常用いられる方法(例えば第
11改正日本薬局方に規定する方法等)に従ってローシ
ョン、乳液、クリーム、ゲル、エアゾール等、各種タイ
プの養毛剤に調製される。The hair nourishing composition of the present invention is prepared into various types of hair nourishing agents such as lotions, milky lotions, creams, gels, aerosols, etc. according to commonly used methods (for example, methods specified in the 11th edition of the Japanese Pharmacopoeia).
[発明の効果]
本発明により、ミノキシジルの養毛効果が著しく高く、
しかも皮膚刺激性などの欠点のない実用的な養毛剤を提
供することが可能となった。[Effects of the Invention] According to the present invention, the hair growth effect of minoxidil is extremely high,
Moreover, it has become possible to provide a practical hair tonic that does not have drawbacks such as skin irritation.
また、本発明により、ミノキシジルの養毛効果を減する
ことなくその従来の配合量より低減することができた。Further, according to the present invention, the amount of minoxidil added can be reduced compared to the conventional amount without reducing the hair-nourishing effect of minoxidil.
[実施例]
以下、実施例と試験例を挙げて本発明を具体的に説明す
る。[Example] Hereinafter, the present invention will be specifically explained with reference to Examples and Test Examples.
(実施例1)
エチルアルコール 80gプロピレング
リコール 5gミノキシジル 、
0.5gグリセリンジカプリル酸エステ
ル 10g上記組成物を撹拌、溶解し、ローションタイ
プの養毛剤を調製した。(Example 1) Ethyl alcohol 80g Propylene glycol 5g Minoxidil,
0.5 g Glycerin dicaprylic acid ester 10 g The above composition was stirred and dissolved to prepare a lotion type hair nourishing agent.
(実施例2)
ミノキシジル 1gグリセリンモ
ノイソ
ステアリン酸エステル
プロピレングリコール
エチルアルコール
g
0g
0g
ポリオキシエチレン(20)
ポリオキシプロピレン〈6)
デシルテトラデシルエーテル
ヒノキチオール
グリチルレチン酸
酢酸トコフェロール
センブリ抽出エキス
ニンジンエキス
!−メントール
酢酸ハイドロコーチシン
塩酸ジフェンヒドラミン
17β−エストラジオール
g
0.2g
0.2g
0.2g
3.6g
g
0.3g
0.0016g
0.1g
O,0008g
上記組成物を、実施例1と同様にして処理し、ローショ
ンタイプの養毛剤を調製した。(Example 2) Minoxidil 1g Glycerin Monoisostearate Propylene Glycol Ethyl Alcohol g 0g 0g Polyoxyethylene (20) Polyoxypropylene <6) Decyl Tetradecyl Ether Hinokitiol Glycyrrhetinic Acetate Tocopherol Assembly Extract Carrot Extract! - Menthol acetate hydrocortiscine hydrochloride diphenhydramine 17β-estradiol g 0.2g 0.2g 0.2g 3.6g g 0.3g 0.0016g 0.1g O,0008g The above composition was treated in the same manner as in Example 1. A lotion-type hair nourishing agent was prepared.
(実施例3)
ミノキシジル 0.5gグリセリ
ンジカプリン酸エステル 5gプロピレングリコール
10gエチルアルコール
40gポリオキシエチレン(60)
硬化ヒマシ油誘導体 2g
カルボキシビニルポリマー
ジイソプロパツールアミン 0.7g上記組成
物を撹拌、混合して、ゲルタイプの養毛剤を調製した。(Example 3) Minoxidil 0.5g Glycerin dicapric acid ester 5g Propylene glycol 10g Ethyl alcohol
40g Polyoxyethylene (60) Hydrogenated castor oil derivative 2g Carboxyvinyl polymer diisopropanolamine 0.7g The above composition was stirred and mixed to prepare a gel type hair growth agent.
(実施例A)
ステアリルアルコール4g1ビタミンEアセテート0.
2g, ヒノキチオール0.1g,グリチルレチン酸
0.2g,グリセリンモノステアリン酸エステル1g,
プロピレングリコールモノイソステアノン酸エステル5
g1スクワラン5g,ffl動パラフィン13g1ポリ
オキシエチレン(20)ソルビタンモノステアリン酸エ
ステル4gを加温しながら撹拌して溶解した。(Example A) 4g stearyl alcohol 1 vitamin E acetate 0.
2g, hinokitiol 0.1g, glycyrrhetinic acid 0.2g, glycerin monostearate 1g,
Propylene glycol monoisostearonate 5
g1 5 g of squalane, 13 g of ffl movable paraffin, 4 g of polyoxyethylene (20) sorbitan monostearate were dissolved by stirring while heating.
あらかじめミノキシジル0.5g,プロピレングリコー
ル7g、バラオキシ安息香酸エチル0.1g1精製水5
9. 9 gを加温しながら撹拌、溶解した液を前記.
溶液に加え、ホモミキサーを用い乳化し、クリームタイ
プの養毛剤を調製した。Minoxidil 0.5g, propylene glycol 7g, ethyl roseoxybenzoate 0.1g 1 purified water 5
9. 9 g was stirred and dissolved while heating.
The mixture was added to the solution and emulsified using a homomixer to prepare a cream-type hair tonic.
(実施例5)
ポリオキシエチレンソルビタンモノオレイン酸エステル
2gと、プロピレングリコールモノイソステアリン酸エ
ステル5gを混合、溶解した。(Example 5) 2 g of polyoxyethylene sorbitan monooleate and 5 g of propylene glycol monoisostearate were mixed and dissolved.
あらかじめ、プロピレングリコール10g,エチルアル
コール10g、精製水68.5g, ミノキシジル0
、5gを撹拌して溶解した液を、前記溶液に加え、撹拌
して乳化した。In advance, add 10 g of propylene glycol, 10 g of ethyl alcohol, 68.5 g of purified water, and 0 minoxidil.
A solution obtained by stirring and dissolving 5 g of the above solution was added to the above solution, and the mixture was stirred and emulsified.
これをエアゾール罐に入れ、これに液化石油ガス4gを
加圧充填し、エアゾールタイプの養毛剤を調製した。This was placed in an aerosol can, and 4 g of liquefied petroleum gas was charged under pressure to prepare an aerosol type hair growth agent.
(試験例1)
ミノキシジル含有組成物の養毛効果試験(1)被験試料
の調製:
前記実施例1の調製方法に準じ、次に示す処方で試料1
〜9、比較試料1〜12及び対照試料1〜2を調製した
。(Test Example 1) Hair growth effect test of minoxidil-containing composition (1) Preparation of test sample: According to the preparation method of Example 1 above, sample 1 was prepared with the following formulation.
-9, comparative samples 1-12 and control samples 1-2 were prepared.
ミノキシジル
エステル
プロピレングリフール
エチルアルコール
0、5g
(第1表参照)
5、0g
(第1表参照)
第1表
※4 表中、GDCIOはグリセリンジカプリン酸エス
テルを、GDC8はグリセリンジカプリル酸エステルを
、GMISはグリセリンモノイソステアリン酸エステル
を、PGMISはプロピレングリコール
モノイソステアリン酸エステルを、
MI はミリスチン酸イソプロピルを、区はグリセリン
モノラウリン酸エステルを、■はプロピレングリコール
モノラウリン酸エステルを、LAはラウリルアルコール
を示す。Minoxidyl ester Propylene Glyfur Ethyl Alcohol 0.5g (See Table 1) 5.0g (See Table 1) Table 1 *4 In the table, GDCIO means glycerin dicaprylate, GDC8 means glycerin dicaprylate, GMIS indicates glycerin monoisostearate, PGMIS indicates propylene glycol monoisostearate, MI indicates isopropyl myristate, ward indicates glycerin monolaurate, ■ indicates propylene glycol monolaurate, and LA indicates lauryl alcohol.
(2)供試動物:
C3)1系マウス(雄性、7週齢)10匹を一群とし、
各群の動物について、その背部の2cmx3cmの範囲
をバリカンで除毛し試験に供した。(2) Test animals: C3) A group of 10 strain 1 mice (male, 7 weeks old),
For each group of animals, hair was removed from a 2 cm x 3 cm area on the back using clippers and used for the test.
(3)養毛試験:
■被験試料1〜9、比較試料1〜12及び対照試料1〜
2の各々にそれぞれ別個の群の供試動物を割り当て、そ
の除毛部に1日1回、o、2mg塗布した。(3) Hair growth test: ■Test samples 1-9, comparative samples 1-12, and control samples 1-
Separate groups of test animals were assigned to each of 2, and 2 mg of the drug was applied once a day to the depilated area.
供試動物の毛の色は黒色で、除毛部の皮膚の色は灰色で
あり、その毛の成長と共に灰色から黒色に色調が変化す
ることから、毛の色の黒さの程度を下記のように測定し
て毛の成長の程度を評価した。The hair color of the test animal is black, and the skin color at the hair removal area is gray, and the tone changes from gray to black as the hair grows, so the degree of blackness of the hair color is determined as follows: The degree of hair growth was evaluated by measuring as follows.
すなわち、分光色差計(高速分光色差計0MS−120
0型、(株)村上色彩技術研究所製)を使用して、LM
a″4b14表色系に基づく除毛直後の被験部のび値、
aM値、b8値と、試料塗布10日後および同20日後
の被験部のL0値、a0値、b′値を測定して、それぞ
れの差ΔL0、Δa0、Δb0を算出し、DE’ab=
((ΔL’)”+(ΔaM)!+(ΔbM ) 1
) 1 / tの式から色差DE’ab値を求め、その
−群の平均値で毛の色の黒さを示した。In other words, a spectrophotometer (high-speed spectrocolorimeter 0MS-120
0 type, manufactured by Murakami Color Research Institute Co., Ltd.), using LM
Test area elongation value immediately after hair removal based on a″4b14 color system,
The aM value, b8 value, and the L0 value, a0 value, and b' value of the test area 10 days and 20 days after application of the sample were measured, and the respective differences ΔL0, Δa0, and Δb0 were calculated, and DE'ab=
((ΔL')”+(ΔaM)!+(ΔbM) 1
) The color difference DE'ab value was determined from the formula 1/t, and the blackness of the hair color was expressed as the average value of the − group.
また、試料塗布後10日後および20日後の被験部の毛
の成長の程度を肉眼により下記の6段階で評価した。In addition, the degree of hair growth in the test area 10 and 20 days after application of the sample was visually evaluated on the following 6 scales.
肉眼評価における判断基準
O:発毛が全く認められない
1:発毛している
2:硬毛が生え揃っている
3:硬毛が正常の約50%生えている
4:硬毛が正常の約75%生えている
5:硬毛が正常の約100%生えてい2この結果を第2
表に示した。Judgment criteria for visual evaluation: O: No hair growth is observed 1: Hair is growing 2: Terminal hair is fully grown 3: Terminal hair is growing at about 50% of the normal level 4: Terminal hair is normal Approximately 75% growth 5: Terminal hair is approximately 100% of normal growth 2 This result is
Shown in the table.
■試料塗布20日後、被験部の2cmX3cmの範囲の
毛をバリカンで刈り取り、その重量を測定してその試料
による毛の成長量とした。20 days after application of the sample, the hair in a 2 cm x 3 cm area of the test area was clipped with clippers, and its weight was measured to determine the amount of hair growth due to the sample.
毛の成長量(mg)と前項■で得た色差DE’ab値の
関係を第1図に示す。The relationship between the amount of hair growth (mg) and the color difference DE'ab value obtained in the previous section (2) is shown in FIG.
この図から両者は明らかに比例関係にあることがわかる
。From this figure, it can be seen that the two are clearly in a proportional relationship.
(試験例2)
ミノキシジル含有製剤の皮膚刺激性評価試験試験例1の
養毛試験において、被験試料を塗布した後の、C3)1
系マウスにおける被験試料塗布部の皮膚の状態を肉眼で
観察し、下記の6段階で被験試料の皮膚刺激性を評価し
た。(Test Example 2) Skin irritation evaluation test for minoxidil-containing preparations In the hair growth test of Test Example 1, after applying the test sample, C3)1
The condition of the skin at the area where the test sample was applied in the mice was visually observed, and the skin irritation of the test sample was evaluated on the following 6 scales.
;皮膚刺激なし
±;軽い紅斑が認められる
+;紅斑が認められる
什;紅斑及び浮腫が認められる
世;紅斑、浮腫及び小水庖が認められる冊;犬水庖が認
められる
この結果を第2表に示した。; No skin irritation±; Slight erythema +; Erythema observed; Erythema and edema observed; Erythema, edema, and small lining observed; Dog sagging observed This result is the second Shown in the table.
* DE’ab値における −は、皮膚が紅斑を生じて
いるため測定不能であることを意味する。* - in the DE'ab value means that measurement is not possible because the skin has erythema.
第1図は毛の成長量と色差DE’abの関係を示すグラ
フである。
第1図
也の成長量(mg)FIG. 1 is a graph showing the relationship between the amount of hair growth and the color difference DE'ab. Figure 1 Growth amount (mg)
Claims (1)
カプリル酸エステル、グリセリンモノイソステアリン酸
エステル及びプロピレングリコールモノイソステアリン
酸エステルからなる群より選ばれるエステルの1種又は
2種以上とミノキシジルを含有することを特徴とする養
毛組成物。(1) It is characterized by containing one or more esters selected from the group consisting of glycerin dicapric acid ester, glycerin dicaprylic acid ester, glycerin monoisostearate, and propylene glycol monoisostearate and minoxidil. Hair nourishing composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63211947A JP2733980B2 (en) | 1988-08-26 | 1988-08-26 | Hair restoration composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63211947A JP2733980B2 (en) | 1988-08-26 | 1988-08-26 | Hair restoration composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0262818A true JPH0262818A (en) | 1990-03-02 |
JP2733980B2 JP2733980B2 (en) | 1998-03-30 |
Family
ID=16614331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63211947A Expired - Fee Related JP2733980B2 (en) | 1988-08-26 | 1988-08-26 | Hair restoration composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2733980B2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06135821A (en) * | 1992-10-30 | 1994-05-17 | Kanebo Ltd | Hair tonic |
JPH07215826A (en) * | 1993-12-07 | 1995-08-15 | Taisho Pharmaceut Co Ltd | Hair tonic |
JPH0812529A (en) * | 1994-06-23 | 1996-01-16 | Riken Health Kk | Transparent hair-raising agent |
WO1998032417A1 (en) * | 1997-01-23 | 1998-07-30 | Taisho Pharmaceutical Co., Ltd. | Persistent hair tonic |
JPH11349451A (en) * | 1998-06-08 | 1999-12-21 | Taisho Pharmaceut Co Ltd | Hair grower |
JP2002173449A (en) * | 2000-12-05 | 2002-06-21 | Kanebo Ltd | Hair-growing agent |
JP2002528401A (en) * | 1998-10-23 | 2002-09-03 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Formulation for topical application of substances with antiandrogenic action |
KR20030021706A (en) * | 2001-09-07 | 2003-03-15 | 주식회사 엘지생활건강 | W/o/w multiple emulsion containing minoxidil |
JP2008266226A (en) * | 2007-04-23 | 2008-11-06 | Pola Chem Ind Inc | External preparation for skin, suitable for cleansing cosmetic |
KR100893469B1 (en) * | 2006-12-22 | 2009-04-17 | 씨제이제일제당 (주) | Compositions containing minoxidil for the hair generation which have an improved skin permeation |
WO2014017573A1 (en) * | 2012-07-27 | 2014-01-30 | 大正製薬株式会社 | Composition for agent for external use |
WO2014119186A1 (en) * | 2013-01-31 | 2014-08-07 | 富士フイルム株式会社 | Emulsion composition |
JP2016138094A (en) * | 2015-01-23 | 2016-08-04 | 大正製薬株式会社 | External composition |
JP2016204362A (en) * | 2015-03-27 | 2016-12-08 | 大正製薬株式会社 | Lotion |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01272515A (en) * | 1988-04-25 | 1989-10-31 | Taisho Pharmaceut Co Ltd | Hair producing agent |
-
1988
- 1988-08-26 JP JP63211947A patent/JP2733980B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01272515A (en) * | 1988-04-25 | 1989-10-31 | Taisho Pharmaceut Co Ltd | Hair producing agent |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06135821A (en) * | 1992-10-30 | 1994-05-17 | Kanebo Ltd | Hair tonic |
JPH07215826A (en) * | 1993-12-07 | 1995-08-15 | Taisho Pharmaceut Co Ltd | Hair tonic |
JPH0812529A (en) * | 1994-06-23 | 1996-01-16 | Riken Health Kk | Transparent hair-raising agent |
WO1998032417A1 (en) * | 1997-01-23 | 1998-07-30 | Taisho Pharmaceutical Co., Ltd. | Persistent hair tonic |
US6255313B1 (en) | 1997-01-23 | 2001-07-03 | Taisho Pharmaceutical Co., Ltd. | Sustained release hair growth composition |
JPH11349451A (en) * | 1998-06-08 | 1999-12-21 | Taisho Pharmaceut Co Ltd | Hair grower |
JP2002528401A (en) * | 1998-10-23 | 2002-09-03 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Formulation for topical application of substances with antiandrogenic action |
JP2002173449A (en) * | 2000-12-05 | 2002-06-21 | Kanebo Ltd | Hair-growing agent |
JP4554805B2 (en) * | 2000-12-05 | 2010-09-29 | 花王株式会社 | Hair nourishing |
KR20030021706A (en) * | 2001-09-07 | 2003-03-15 | 주식회사 엘지생활건강 | W/o/w multiple emulsion containing minoxidil |
KR100893469B1 (en) * | 2006-12-22 | 2009-04-17 | 씨제이제일제당 (주) | Compositions containing minoxidil for the hair generation which have an improved skin permeation |
JP2008266226A (en) * | 2007-04-23 | 2008-11-06 | Pola Chem Ind Inc | External preparation for skin, suitable for cleansing cosmetic |
WO2014017573A1 (en) * | 2012-07-27 | 2014-01-30 | 大正製薬株式会社 | Composition for agent for external use |
JPWO2014017573A1 (en) * | 2012-07-27 | 2016-07-11 | 大正製薬株式会社 | External preparation composition |
WO2014119186A1 (en) * | 2013-01-31 | 2014-08-07 | 富士フイルム株式会社 | Emulsion composition |
JPWO2014119186A1 (en) * | 2013-01-31 | 2017-01-26 | 富士フイルム株式会社 | Emulsified composition |
US9730866B2 (en) | 2013-01-31 | 2017-08-15 | Fujifilm Corporation | Emulsion composition |
JP2016138094A (en) * | 2015-01-23 | 2016-08-04 | 大正製薬株式会社 | External composition |
JP2016204362A (en) * | 2015-03-27 | 2016-12-08 | 大正製薬株式会社 | Lotion |
JP2020105217A (en) * | 2015-03-27 | 2020-07-09 | 大正製薬株式会社 | Lotion |
Also Published As
Publication number | Publication date |
---|---|
JP2733980B2 (en) | 1998-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101769637B1 (en) | Compositions and methods for stimulating hair growth | |
EP0238302B1 (en) | Skin treatment composition | |
PT715856E (en) | Keratin-storable antifungal composition for external use | |
AU2014242317B2 (en) | Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith | |
PT1562531E (en) | Topical skin care composition | |
JP2002284705A (en) | Torpent | |
JPH0262818A (en) | Hair-tonic composition | |
JPH10298027A (en) | Aqueous cosmetic composition containing stably solubilized uric acid and water-soluble polymer material and stable solubilization of uric acid in the aqueous cosmetic composition | |
US4742066A (en) | Skin treatment composition and method | |
JP4554805B2 (en) | Hair nourishing | |
JPH1179951A (en) | Tyrosinase activity promoter | |
US20040141935A1 (en) | Reduction of hair growth | |
JP2663136B2 (en) | Whitening cosmetics | |
CA1253807A (en) | Topical composition for the protection and treatment of human skin or hair | |
JP2906269B2 (en) | External preparation for skin | |
JP3314785B2 (en) | Minoxidil-containing hair restorer | |
JPH0971513A (en) | Hair tonic | |
KR100336005B1 (en) | Wool composition | |
JPH06316553A (en) | Application of alkanolamine | |
US5439676A (en) | cAMP derivatives and use thereof for preventing or restoring grayed hair to its natural color | |
JP2600794B2 (en) | Hair growth agent | |
JPH0449216A (en) | Melanin inhibitor | |
JPH04234804A (en) | Hair restorer | |
JP2000281555A (en) | Skin preparation for external use | |
JPH01132510A (en) | Hair tonic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |